inforMED
InjuryMOZ

DUROLANE INJECTION

Received Oct 5, 2022

Report MW5112461 · MDR key 15550588

Device

Generic name

Acid, Hyaluronic, Intraarticular

Manufacturer

Bioventus Llc.

Product problems

  • Adverse Event Without Identified Device or Use Problem

Patient

41 YR · Female

  • Pain
  • Rash
  • Swelling/ Edema
  • Pain
  • Rash
  • Swelling/ Edema

Narrative

Description of Event or Problem

PATIENT WAS PRESCRIBED AND ADMINISTERED DUROLANE INJECTION BILATERAL KNEES ON (B)(6) 2022; SHE EXPERIENCED EXACERBATION POSSIBLY FROM DUROLANE INJECTION; INCREASE PAIN/TENDER TO TOUCH, SWELLING AND RASH/ RED LESIONS ON BILATERAL EXTREMITIES; NO RELIEF WITH BENADRYL, TAKING MEDROL DOSE PAK; SHE MISSED A WEEK OF WORK AND PLANNED ACTIVITIES DUE TO THE EXACERBATION/REACTION (HAS RETURNED TO WORK TODAY (B)(6) 2022). THERAPY IS NOT ONGOING.